Abstract | BACKGROUND: AIM: MATERIALS AND METHODS: forty patients participated in the study. Baseline examination included visual acuity, refraction, slit-lamp examination, intraocular pressure, anterior and posterior segment examination, gonioscopy and perimetry. Patients were treated with Latanoprost 0.005% once daily at bedtime. IOP was recorded at baseline, 2weeks, 4 weeks, 8 weeks and 12 weeks after starting the treatment. RESULTS: the mean age of the study sample was 56.45 years (40-70 years). There were 18 males and 22 females in the study. Mean IOP at baseline was 24.55 +/- 3.63. Mean IOP decreased to 17.27 +/- 3.19 at 2 weeks, 15.27 +/- 3.07 at 4 weeks, 14.60-3.06 at 8 weeks and 14.47 +/- 2.66 at 12 weeks. There was a statistically significant reduction in mean IOP (41.03%) at 12 weeks as compared to those of the baseline IOP (p=0.000). There was no significant difference in IOP reduction in eyes with different degrees of angle closure by peripheral anterior synechiae. CONCLUSION:
|
Authors | S Kumar, A Malik, M Singh, S Sood |
Journal | Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
(Nepal J Ophthalmol)
2009 Jan-Jun
Vol. 1
Issue 1
Pg. 32-6
ISSN: 2072-6805 [Print] Nepal |
PMID | 21141019
(Publication Type: Comparative Study, Journal Article, Multicenter Study)
|
Chemical References |
- Antihypertensive Agents
- Prostaglandins F, Synthetic
- Latanoprost
|
Topics |
- Adult
- Aged
- Antihypertensive Agents
(administration & dosage, therapeutic use)
- Chronic Disease
- Female
- Follow-Up Studies
- Glaucoma, Angle-Closure
(drug therapy, physiopathology)
- Gonioscopy
- Humans
- Intraocular Pressure
(drug effects)
- Latanoprost
- Male
- Middle Aged
- Prostaglandins F, Synthetic
(administration & dosage, therapeutic use)
- Treatment Outcome
|